Clinical trial
Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in…
NCT00199602 · University Hospital, Limoges, Other · Completed
Key facts
| NCT number | NCT00199602 |
|---|---|
| Title | Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients |
| Official title | Prophylaxis of Thrombosis With Implantable Devices for Central Venous Access in Cancer Patients : Phase III Randomised Study |
| Lead sponsor | University Hospital, Limoges, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | warfarine - low molecular heparin |
| Enrollment | 420 |
| Start date | Aug 1, 1999 |
| Primary completion | Dec 1, 2009 |
| Completion | Dec 1, 2010 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 24, 2018 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: